Lurenz v. The Coca-Cola Company

Background

Joseph Lurenz sued The Coca-Cola Company and The Simply Orange Juice Company on behalf of himself and a proposed class. He alleged that the defendants’ Simply Tropical juice drink was falsely labeled as an “All Natural” product made with “all-natural ingredients,” even though it contained multiple substances known as per- and polyfluoroalkyl substances, or PFAS. Lurenz alleged that independent testing found PFAS in a sample collected in July 2022. He claimed economic injury because he paid more for the product than he would have paid if he had known that it contained or risked containing PFAS. He did not allege that he or anyone else suffered physical harm from consuming the product.

The amended complaint asserted claims under the Magnuson-Moss Warranty Act, New York’s consumer-protection statutes, New York’s Agriculture and Markets Law, and state-law theories including breach of express warranty, negligence per se, and unjust enrichment. The defendants moved to dismiss under Federal Rule of Civil Procedure 12(b)(1), which addresses subject-matter jurisdiction, and Rule 12(b)(6), which addresses whether a complaint states a legally sufficient claim.

Standing ruling

The court considered the jurisdictional standing issue first. To establish Article III standing, a plaintiff must show a concrete and particularized injury, a connection between that injury and the defendant’s conduct, and that a favorable court decision could remedy the injury. In a proposed class action, the named plaintiff must personally have suffered an injury and cannot rely on possible injuries to unnamed class members.

The court recognized that paying a premium for a product with an allegedly misleading label can qualify as an injury. But it held that Lurenz had not plausibly alleged that he personally bought a product containing PFAS. His allegations relied on testing of a single sample, not the products he actually purchased. The amended complaint did not say how many products were tested, whether all tested products contained PFAS, what percentage contained PFAS, or whether PFAS was widespread enough to make it plausible that Lurenz bought a mislabeled product. The court also found that the fact that the testing and Lurenz’s purchase occurred in the same month was not enough to connect the test result to his purchases.

The court concluded that the allegations described general and unspecific testing results without meaningfully linking them to Lurenz’s purchased products. It therefore held that Lurenz had not shown an injury in fact and lacked Article III standing.

Disposition

Because it granted the defendants’ motion under Rule 12(b)(1), the court did not decide the defendants’ remaining Rule 12(b)(6) arguments. The court granted the defendants’ motion to dismiss and dismissed the amended complaint without prejudice.

The court also granted Lurenz leave to file a Second Amended Complaint. The order set July 10, 2024, as the filing deadline and July 31, 2024, as the deadline for the defendants to answer or otherwise respond. The court stated that if Lurenz failed to file the Second Amended Complaint on time and could not show good cause, claims dismissed without prejudice by the order would be deemed dismissed with prejudice. The order directs the Clerk of Court to terminate the defendants’ motion at ECF No. 31.